DISINTEGRATION
TEST FOR SUGAR-COATED TABLETS
OBJECTIVE
1. To study and evaluate disintegration test for sugar-coated
tablets.
2. To determine whether sugar-coated tablets
disintegrate within 60 minutes when placed in a liquid medium at 37oC.
INTRODUCTION
Coated
tablets are tablets covered with one or more layers of mixtures of substances
such as natural or synthetic resins, polymers, gums, fillers, sugars,
plasticizers, polyols, waxes, colouring matters, and flavouring substances. The
tablets maybe coated for a variety of reasons such as protection of the active
ingredients from air, moisture or light, masking of unpleasant tastes and odours
or improvement of appearance. The substance used for coating is usually applied
as a solution or suspension.
In this
experiment, the apparatus used is basket-rack assembly which consists of six
open-ended transparent tubes. The tubes are held in a vertical position by two
plates with six holes, equidistant from the center of the plate and equally
spaced from one another. A suitable means is provided to suspend the
basket-rack assembly from the raising and lowering device using a point on its
axis.
METHOD
Apparatus
Basket-rack assembly and disks
Materials
Sugar-coated tablets, distilled water
Procedures
1. The
apparatus for the disintegration test was set up according to its operation
manual.
2. The
temperature of the disintegration medium (water) was ensured at 37±2oC.
3. The
time was set to 60 minutes. One tablet was introduced into each tube, the disk
was added into each tube and the operation was started.
5. The
tablets comply with the test if all 6 tablets disintegrate in 60 minutes. If
there is any tablet does not disintegrate, the test was repeated using 6 new
tablets by replacing the disintegration medium (water) with 0.1M hydrochloric
acid. The tablets comply with the test if all 6 tablets disintegrate in the
acidic medium.
RESULTS
All the 6 tablets disintegrate in the disintegration
medium (water) within 60 minutes.
DISCUSSION
When
a tablet is administered into body, it must be first disintegrate into smaller
particles before it is absorbed into body. In this experiment, disintegration
test of tablets is carried out by putting it in a basket-rack assembly, which
will be lowered into disintegration medium(water) at 37oC for 60 minutes. The tablet is continually
hammered by a plastic disk to stimulate in vivo conditions. At the end of the experiment,
all the 6 tablets have been disintegrated within 60 minutes, thus the tablet is
considered to pass the test providing if no tablet residue remains on the mesh
after 60 minutes. When the time limit (60 minutes) has been reached, there is
still a little amount of fragments of the tablets left, squish it using finger
to check whether the fragments are coating or they have not been disintegrated
yet. After squishing, if the fragments crack, the fragments proved to be
coating and tablets considered to pass the disintegration test. If the
fragments are hard and do not break, then the fragments fail in the
disintegration test. Hence, the test needs to be repeated using same number of
tablets but in the medium of 0.1M hydrochloric acid. In this testing, after
squishing, all the tablets crack and success in the disintegration test.
However, this test is not a true indicator
about how well the dosage form will release its active ingredient in vivo. This
is due to some limitations. Firstly, it does not mimic conditions of
gastrointestinal tract such as the peristaltic movement. Secondly, this test is
controlled by experimental variables. There are a few errors occured in this
experiment. The dissolution medium is not heated up adequately. Hence, it
affects the disintegration process and integration rate. To reduce this error,
use a thermometer to measure the temperature of the disintegration medium is
constant (37±2oC).
CONCLUSION
All the tablets disintegrate in the disintegrate
medium (water) within 60 minutes, thus the tablets comply with the
disintegration test.
REFERENCE
B.
Dissolution test for tablets
OBJECTIVE
To determine the percentage amount of Ibuprofen
tablet dissolved in the dissolution medium.
INTRODUCTION
Ibuprofen
is a nonsteroidal anti-inflammatory drug (NSAID) and used as an analgesic and
antipyretic. It has a pKa value of 4.5 and is poorly absorbed in water. Drug
dissolution is the rate limiting step in the drug absorption process. Paddle
method used at a paddle speed of 150rpm, in dissolution medium at 37±0.5oC,
with UV spectrophotometer. The ibuprofen concentration is
spectrophotometrically determined at 221nm using the following formula:
The
dissolution test is a simple and useful in vitro tool that can provide valuable
information about drug release similarity among different batches and brands.
It describes about manufacturing reproducibility, product performance similarity
and bioavailability of drug from its formulation.
Structure of Ibuprofen
METHOD
Apparatus:
Tablet dissolution tester with paddle,
spectrophotometer, droplet, syringe, beaker, 50mL volumetric flask, stopper,
cuvette
Materials:
Ibuprofen tablet, distilled water, buffer solution,
standard ibuprofen solution,
Procedures:
1. Each
of the dissolution vessels is filled up with the buffer solution to 900ml mark.
The temperature to 37oC.
2. The
temperature of the dissolution medium is checked. It is ensured at 37±0.5oC.
4. The
stirring speed is set to 150rpm. The basket assembly is lowered into position
in the vessel and starts the operation.
5. After
30 minutes, 10ml samples of the dissolution medium is withdrawn from each
vessel for analysis and the solution is filtered using suitable filter.
Sampling should be done from a point half-way between the surface of the
dissolution medium and the top of the rotating basket, not less than 10mm from
the wall of the vessel. The volume of aliquot withdrawn for analysis is
replaced with an equal amount of same dissolution medium.
6. A
standard solution of Ibuprofen is prepared by diluting 10.0mg of ibuprofen
reference standard to 50ml with dissolution medium.
7. 2.0ml
of sample solution 2.0ml of standard solution are diluted to 25ml with
dissolution medium in separate volumetric flasks.
9. The
percentage amount of ibuprofen dissolved is calculated using the following
formula:
Where At= absorbance of sample solution
As = absorbance of the standard solution
W = weight of ibuprofen reference
standard used
P = purity of ibuprofen reference
standard
10. From
the results obtained, the tablets are determined whether comply with the
requirements of the United States Pharmacopoeia.
RESULTS
Absorbance of sample solution At
|
0.985
|
Absorbance of standard solution, As
|
0.767
|
DISCUSSION
The percentage
amount of Ibuprofen is 113.27%, more than 75% of the stated amount of C13H18O2
dissolved in 30 minutes. Hence, Ibuprofen dissolves in the dissolution medium
and achieves the USP standard. The active ingredient dissolves throughout the
dissolution medium thus the percentage of active ingredient is low. This
indicates the active ingredient soluble in the medium quickly and takes less
time to become soluble completely.
There are a few important aspects that need
to take into account during the experiment. Firstly, the temperature of the
dissolution medium should be monitored and maintained at 37±0.5oC.
Lower temperature may cause poor dissolution of Ibuprofen tablets, while higher
temperature may alter the composition of the ibuprofen tablet. The stirring
speed should be maintained at 150rpm. Low speed causes slow dissolution rate.
The duration of stirring should be set at 30minutes. There should be no air
bubbles inside the syringe when taking sample solution and standard solution.
The cuvette should be hold at the gross side as holding at the smooth side will
left the fingerprints on the surface and affect the result of
spectrophotometer.
CONCLUSION
The percentage amount of Ibuprofen is 113.27%, more than 75% of
the stated amount of C13H18O2 dissolved in 30
minutes, thus it comply with the requirement of United States Pharmacopoeia for
tablet’s dissolution test.
REFERENCE
.gif)














The pollution of pharmaceutical products poses a serious hazard to public health, and therefore, for the production process, formulation and performance of pharmaceutical products, and final product quality acceptance, Pharmaceutical testing
ReplyDelete